Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000899243-23-012758

Chief Business Officer sold 44,000 shares at an average $23.93 ($1,053,080)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Robb Gary Charles Chief Business Officer 2023-05-09 Sale −30,000 $23.87 $716,100 33,997 D
Robb Gary Charles Chief Business Officer 2023-05-10 Sale −14,000 $24.07 $336,980 19,997 D
Open-market sales · 44,000 sh · avg $23.93 · $1,053,080
Loading xslF345X04/doc4.xml…